Humana (HUM) has quietly climbed about 11% over the past month, outpacing its performance over the past 3 months and 3 years. That move has investors rechecking what they are really paying for its ...

Humana trades near fair value, reflecting a mixed profit outlook and Medicare Advantage uncertainties. Click here to read an ...

The bearish sentiment is evident in the stock's price action. Shares are currently trading at €284.40, a steep decline from their 52-week high of €532.50 and down more than 40% year-to-date. This ...

Shares of Tesla close on a record high.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 ...

Humana ( ($HUM) ) has shared an announcement. On December 16, 2025, Humana announced the retirement of George Renaudin, Insurance Segment ...

The fair value estimate for Humana has nudged higher to about $288 from roughly $287 as analysts factor in slightly stronger long term revenue growth assumptions around 9.5%, supported by improving ...

The Zacks Consensus Estimate for UnitedHealth Group’s 2025 earnings is pegged at $16.29 per share. The consensus mark for ...

Four of the “magnificent 7” stocks have decided to invest a massive $380 billion in 2025 as capital expenditure for ...

Earlier this month, Humana cut its full-year earnings outlook, citing ongoing pressure in its Medicare Advantage business ...

In a notable shift for investors, Humana Inc. (NYSE: HUM) received a ‘Buy’ rating from Jefferies analyst David Windley o. The analyst suggests a price target of $313, representing a significant upside ...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...